Table 2.
Agency for Healthcare Research Quality (AHRQ) Patient Safety Indicators (PSI) stratified by tertile of GFR
| AHRQ Patent Safety Indicator (PSI) Present | ||||
|---|---|---|---|---|
|
Yes
|
No
|
|||
| N | % | N | % | |
| Participant Observed Rate | 978 | 38.9 | 1536 | 61.1 |
| Low tertile GFR | 406 | 45.2 | 492 | 54.8 |
| Middle tertile GFR | 290 | 36.8 | 497 | 63.2 |
| High tertile GFR | 255 | 33.5 | 507 | 66.5 |
|
| ||||
|
| ||||
| Hospitalizations Observed Rate | 1606 | 20.2 | 6333 | 79.8 |
| Low tertile GFR | 663 | 22.4 | 2334 | 77.6 |
| Middle tertile GFR | 468 | 19.7 | 1865 | 80.3 |
| High tertile GFR | 423 | 17.5 | 1905 | 82.5 |
p-value <.0001 for participant observed differences in rates for GFR, P value = 0.004 for hospitalization observed differences in rate for GFR. Based on chi-square test GFR=estimated glomerular filtration rate